Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.
about
Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling.Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate.
P2860
Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preclinical and clinical evalu ...... cells and in the tumor stroma.
@en
type
label
Preclinical and clinical evalu ...... cells and in the tumor stroma.
@en
prefLabel
Preclinical and clinical evalu ...... cells and in the tumor stroma.
@en
P2860
P356
P1433
P1476
Preclinical and clinical evalu ...... cells and in the tumor stroma
@en
P2093
V Finisguerra
P2860
P2888
P304
P356
10.1038/ONC.2016.36
P407
P577
2016-03-21T00:00:00Z
P6179
1011077933